WNT5A and melanoma: On the other hand, the potential role for increased Wnt5a expression in malignant melanoma has recently been outlined as a study established that nuclear beta-catenin levels are higher in primary tumors than in metastases and that low expression of nuclear beta-catenin expression in primary tumors predicts poor survival [56].